Hologic Announces Financial Results for First Quarter of Fiscal 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Hologic (HOLX) Tops Q1 EPS by 69c, Revenues Beat; Offers 2Q EPS/Revenue Guidance Above Consensus
January 27, 2021 4:06 PM ESTHologic (NASDAQ: HOLX) reported Q1 EPS of $2.86, $0.69 better than the analyst estimate of $2.17. Revenue for the quarter came in at $1.61 billion versus the consensus estimate of $1.4 billion.
Revenue of $1.61 Billion Increases 89.3%, 86.5% in Constant Currency Organic Revenue Increases 107.0%, 104.0% in Constant Currency Company Posts GAAP Diluted EPS of $2.50, Non-GAAP Diluted EPS of $2.86Hologic had a strong start to fiscal 2021 across... More
